PHARMANUTRA SPA (PHN.MI) Stock Fundamental Analysis
BIT:PHN - Euronext Milan - IT0005274094 - Common Stock - Currency: EUR
Taking everything into account, PHN scores 7 out of 10 in our fundamental rating. PHN was compared to 13 industry peers in the Personal Care Products industry. PHN gets an excellent profitability rating and is at the same time showing great financial health properties. PHN is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes PHN very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year PHN was profitable.
PHN had a positive operating cash flow in the past year.
Each year in the past 5 years PHN has been profitable.
Each year in the past 5 years PHN had a positive operating cash flow.
1.2 Ratios
The Return On Assets of PHN (18.91%) is better than 100.00% of its industry peers.
With an excellent Return On Equity value of 36.18%, PHN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 23.97%, PHN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for PHN is above the industry average of 12.26%.
The 3 year average ROIC (17.21%) for PHN is below the current ROIC(23.97%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.91% | ||
| ROE | 36.18% | ||
| ROIC | 23.97% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
1.3 Margins
Looking at the Profit Margin, with a value of 13.77%, PHN is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
In the last couple of years the Profit Margin of PHN has declined.
With an excellent Operating Margin value of 22.67%, PHN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
PHN's Operating Margin has been stable in the last couple of years.
PHN's Gross Margin of 95.55% is amongst the best of the industry. PHN outperforms 100.00% of its industry peers.
In the last couple of years the Gross Margin of PHN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.67% | ||
| PM (TTM) | 13.77% | ||
| GM | 95.55% |
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
PHN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, PHN has about the same amount of shares outstanding.
The number of shares outstanding for PHN has been reduced compared to 5 years ago.
Compared to 1 year ago, PHN has an improved debt to assets ratio.
2.2 Solvency
PHN has an Altman-Z score of 8.19. This indicates that PHN is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 8.19, PHN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Debt to FCF ratio of PHN is 1.16, which is an excellent value as it means it would take PHN, only 1.16 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.16, PHN belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
PHN has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
PHN's Debt to Equity ratio of 0.30 is in line compared to the rest of the industry. PHN outperforms 53.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 1.16 | ||
| Altman-Z | 8.19 |
ROIC/WACC2.92
WACC8.22%
2.3 Liquidity
A Current Ratio of 2.29 indicates that PHN has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.29, PHN belongs to the top of the industry, outperforming 92.31% of the companies in the same industry.
A Quick Ratio of 2.02 indicates that PHN has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.02, PHN belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.29 | ||
| Quick Ratio | 2.02 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 29.72% over the past year.
The Earnings Per Share has been growing by 14.63% on average over the past years. This is quite good.
Looking at the last year, PHN shows a quite strong growth in Revenue. The Revenue has grown by 16.16% in the last year.
PHN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.59% yearly.
EPS 1Y (TTM)29.72%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%-8.63%
Revenue 1Y (TTM)16.16%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%11.2%
3.2 Future
PHN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.90% yearly.
The Revenue is expected to grow by 11.78% on average over the next years. This is quite good.
EPS Next Y16.46%
EPS Next 2Y15.44%
EPS Next 3Y12.9%
EPS Next 5YN/A
Revenue Next Year14.39%
Revenue Next 2Y13.19%
Revenue Next 3Y11.78%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 19.38 indicates a rather expensive valuation of PHN.
Compared to the rest of the industry, the Price/Earnings ratio of PHN indicates a rather cheap valuation: PHN is cheaper than 92.31% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of PHN to the average of the S&P500 Index (26.32), we can say PHN is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 18.50, the valuation of PHN can be described as rather expensive.
PHN's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of PHN to the average of the S&P500 Index (22.19), we can say PHN is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.38 | ||
| Fwd PE | 18.5 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHN indicates a somewhat cheap valuation: PHN is cheaper than 61.54% of the companies listed in the same industry.
PHN's Price/Free Cash Flow ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.94 | ||
| EV/EBITDA | 10.38 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of PHN may justify a higher PE ratio.
PHN's earnings are expected to grow with 12.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.18
PEG (5Y)1.32
EPS Next 2Y15.44%
EPS Next 3Y12.9%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.02%, PHN has a reasonable but not impressive dividend return.
PHN's Dividend Yield is comparable with the industry average which is at 2.56.
Compared to an average S&P500 Dividend Yield of 2.40, PHN has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.02% |
5.2 History
The dividend of PHN is nicely growing with an annual growth rate of 11.21%!
Dividend Growth(5Y)11.21%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
35.05% of the earnings are spent on dividend by PHN. This is a low number and sustainable payout ratio.
The dividend of PHN is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP35.05%
EPS Next 2Y15.44%
EPS Next 3Y12.9%
BIT:PHN (6/18/2025, 4:18:55 PM)
46.9
+0.05 (+0.11%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)
Earnings (Next)
Inst Owners15.44%
Inst Owner ChangeN/A
Ins Owners65.02%
Ins Owner ChangeN/A
Market Cap453.99M
Analysts82.86
Price Target83.64 (78.34%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.02% |
Yearly Dividend0.85
Dividend Growth(5Y)11.21%
DP35.05%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.2%
PT rev (3m)-2.77%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-2.37%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.82%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.38 | ||
| Fwd PE | 18.5 | ||
| P/S | 2.68 | ||
| P/FCF | 21.94 | ||
| P/OCF | 18.27 | ||
| P/B | 7.04 | ||
| P/tB | 11.1 | ||
| EV/EBITDA | 10.38 |
EPS(TTM)2.42
EY5.16%
EPS(NY)2.54
Fwd EY5.41%
FCF(TTM)2.14
FCFY4.56%
OCF(TTM)2.57
OCFY5.47%
SpS17.49
BVpS6.66
TBVpS4.22
PEG (NY)1.18
PEG (5Y)1.32
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.91% | ||
| ROE | 36.18% | ||
| ROCE | 41.7% | ||
| ROIC | 23.97% | ||
| ROICexc | 35.83% | ||
| ROICexgc | 57.7% | ||
| OM | 22.67% | ||
| PM (TTM) | 13.77% | ||
| GM | 95.55% | ||
| FCFM | 12.22% |
ROA(3y)13.53%
ROA(5y)17.42%
ROE(3y)26.61%
ROE(5y)29.54%
ROIC(3y)17.21%
ROIC(5y)18.21%
ROICexc(3y)25.61%
ROICexc(5y)33.67%
ROICexgc(3y)43.23%
ROICexgc(5y)50.61%
ROCE(3y)29.76%
ROCE(5y)31.61%
ROICexcg growth 3Y-15.98%
ROICexcg growth 5Y-10.26%
ROICexc growth 3Y-20.69%
ROICexc growth 5Y-11.75%
OM growth 3Y-4.84%
OM growth 5Y1.01%
PM growth 3Y-10.74%
PM growth 5Y-1.82%
GM growth 3Y-0.75%
GM growth 5Y-0.04%
F-Score8
Asset Turnover1.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.3 | ||
| Debt/FCF | 1.16 | ||
| Debt/EBITDA | 0.46 | ||
| Cap/Depr | 106.2% | ||
| Cap/Sales | 2.46% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 58.76% | ||
| Profit Quality | 88.74% | ||
| Current Ratio | 2.29 | ||
| Quick Ratio | 2.02 | ||
| Altman-Z | 8.19 |
F-Score8
WACC8.22%
ROIC/WACC2.92
Cap/Depr(3y)763.09%
Cap/Depr(5y)544.05%
Cap/Sales(3y)14.97%
Cap/Sales(5y)11.04%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.72%
EPS 3Y6.71%
EPS 5Y14.63%
EPS Q2Q%-8.63%
EPS Next Y16.46%
EPS Next 2Y15.44%
EPS Next 3Y12.9%
EPS Next 5YN/A
Revenue 1Y (TTM)16.16%
Revenue growth 3Y19.25%
Revenue growth 5Y16.59%
Sales Q2Q%11.2%
Revenue Next Year14.39%
Revenue Next 2Y13.19%
Revenue Next 3Y11.78%
Revenue Next 5YN/A
EBIT growth 1Y19.75%
EBIT growth 3Y13.47%
EBIT growth 5Y17.77%
EBIT Next Year24.88%
EBIT Next 3Y16.72%
EBIT Next 5Y9.17%
FCF growth 1Y235.79%
FCF growth 3Y1.75%
FCF growth 5Y17.94%
OCF growth 1Y134.99%
OCF growth 3Y0.14%
OCF growth 5Y11.34%